Recruiting
Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy
NCT07606352
- Conditions
- IgAN
- Locations
-
- Research Site Woolloongabba, Queensland, Australia
- Research Site Clayton, Victoria, Australia
- Research Site Saint Albans, Victoria, Australia